Skip to main content
Fig. 1 | Clinical Sarcoma Research

Fig. 1

From: Preoperative accelerated radiotherapy combined with chemotherapy in a defined cohort of patients with high risk soft tissue sarcoma: a Scandinavian Sarcoma Group study

Fig. 1

Treatment schedule. Chemotherapy (CT): ≥ 18 and < 70 years of age: Day 1: doxorubicin 60 mg/m2, 4-h infusion (IV); Day 1, 2 and 3: ifosfamide 2 g/m2/day as 2-h infusion, dose per cycle 6 g/m2 [with an equal dose of 2-mercaptoethane sulphonate sodium (MESNA)]. ≥ 70 and ≤ 75 years: doxorubicin 50 mg/m2 and ifosfamide 5 g/m2 (given as above). Granulocyte colony-stimulating factor was given routinely after each cycle

Back to article page

Clinical Sarcoma Research

ISSN: 2045-3329